Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants
98
mi
from 91732
Santa Barbara, CA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
98
mi
from 91732
Santa Barbara, CA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Bay Area Retina Associates
348
mi
from 91732
Walnut Creek, CA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Bay Area Retina Associates
348
mi
from 91732
Walnut Creek, CA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Southern
804
mi
from 91732
Colorado Springs, CO
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Southern
804
mi
from 91732
Colorado Springs, CO
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Colorado Retina Associates
807
mi
from 91732
Golden, CO
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Colorado Retina Associates
807
mi
from 91732
Golden, CO
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Rand Eye
2312
mi
from 91732
Deerfield Beach, FL
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Rand Eye
2312
mi
from 91732
Deerfield Beach, FL
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
National Ophthalmic Research Institute
2209
mi
from 91732
Fort Myers, FL
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
National Ophthalmic Research Institute
2209
mi
from 91732
Fort Myers, FL
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Florida Eye Associates
2238
mi
from 91732
Melbourne, FL
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Florida Eye Associates
2238
mi
from 91732
Melbourne, FL
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Specialty Institute
1810
mi
from 91732
Pensacola, FL
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Specialty Institute
1810
mi
from 91732
Pensacola, FL
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Assoc of FL
2127
mi
from 91732
Saint Petersburg, FL
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Assoc of FL
2127
mi
from 91732
Saint Petersburg, FL
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Southern Vitreoretinal Assoc
1979
mi
from 91732
Tallahassee, FL
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Southern Vitreoretinal Assoc
1979
mi
from 91732
Tallahassee, FL
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Southeast Retina Center, P.C.
2059
mi
from 91732
Augusta, GA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Southeast Retina Center, P.C.
2059
mi
from 91732
Augusta, GA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
University of Illinois at Chicago
1729
mi
from 91732
Chicago, IL
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
University Retina and Macula Associates, P.C.
1721
mi
from 91732
Oak Forest, IL
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
University Retina and Macula Associates, P.C.
1721
mi
from 91732
Oak Forest, IL
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Illinois Retina Associates, SC
1722
mi
from 91732
Oak Park, IL
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Illinois Retina Associates, SC
1722
mi
from 91732
Oak Park, IL
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Midwest Eye Institute
1793
mi
from 91732
Indianapolis, IN
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Midwest Eye Institute
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Wolfe Eye Clinic
1415
mi
from 91732
West Des Moines, IA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
1415
mi
from 91732
West Des Moines, IA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Kentucky
1886
mi
from 91732
Lexington, KY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Kentucky
1886
mi
from 91732
Lexington, KY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Paducah Retinal Center
1659
mi
from 91732
Paducah, KY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Paducah Retinal Center
1659
mi
from 91732
Paducah, KY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Elman Retina Group, PA
2307
mi
from 91732
Baltimore, MD
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Elman Retina Group, PA
2307
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Wilmer Eye Institute
2301
mi
from 91732
Baltimore, MD
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Wilmer Eye Institute
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Vitreo-Retinal Associates
1843
mi
from 91732
Grand Rapids, MI
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Vitreo-Retinal Associates
1843
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Michigan
1958
mi
from 91732
Southfield, MI
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Michigan
1958
mi
from 91732
Southfield, MI
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Vitreoretinal Surgery
1504
mi
from 91732
Edina, MN
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Vitreoretinal Surgery
1504
mi
from 91732
Edina, MN
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Sierra Eye Associates
385
mi
from 91732
Reno, NV
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Sierra Eye Associates
385
mi
from 91732
Reno, NV
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Center of New Jersey, LLC
2423
mi
from 91732
Bloomfield, NJ
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Center of New Jersey, LLC
2423
mi
from 91732
Bloomfield, NJ
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Eye Associates of New Mexico
mi
from 91732
Albuquerque, NM
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Eye Associates of New Mexico
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
648
mi
from 91732
Albuquerque, NM
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
648
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Capital Region Retina, PLLC
2440
mi
from 91732
Albany, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Capital Region Retina, PLLC
2440
mi
from 91732
Albany, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Opthalmic Consultants of LI
2450
mi
from 91732
Lynbrook, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Opthalmic Consultants of LI
2450
mi
from 91732
Lynbrook, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Vitreous-Retina-Macula
2434
mi
from 91732
New York, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Vitreous-Retina-Macula
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Eye Associates; NewYork-Presbyterian Hospital/Weill Cornell Medical Center
2435
mi
from 91732
New York, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Eye Associates; NewYork-Presbyterian Hospital/Weill Cornell Medical Center
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Western New York
2187
mi
from 91732
Orchard Park, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Western New York
2187
mi
from 91732
Orchard Park, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Vit Surgeons/Central NY
2321
mi
from 91732
Syracuse, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Vit Surgeons/Central NY
2321
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
West Carolina Retinal AssocPA
2004
mi
from 91732
Asheville, NC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
West Carolina Retinal AssocPA
2004
mi
from 91732
Asheville, NC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Char Eye Ear &Throat Assoc
2102
mi
from 91732
Charlotte, NC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Char Eye Ear &Throat Assoc
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Cincinnati Eye Institute
1880
mi
from 91732
Cincinnati, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Assoc. of Cleveland
2041
mi
from 91732
Cleveland, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Assoc. of Cleveland
2041
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation; Cole Eye Institute
2036
mi
from 91732
Cleveland, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation; Cole Eye Institute
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
OSU Eye Physicians and Surgeons, LLC.
1960
mi
from 91732
Columbus, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
OSU Eye Physicians and Surgeons, LLC.
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Oregon Retina, LLP
740
mi
from 91732
Eugene, OR
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Oregon Retina, LLP
740
mi
from 91732
Eugene, OR
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Northwest, PC
827
mi
from 91732
Portland, OR
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Northwest, PC
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Retinal Spec.
2281
mi
from 91732
Camp Hill, PA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Retinal Spec.
2281
mi
from 91732
Camp Hill, PA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Associates in Ophthalmology
2123
mi
from 91732
West Mifflin, PA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Associates in Ophthalmology
2123
mi
from 91732
West Mifflin, PA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Charleston Neuroscience Inst
2172
mi
from 91732
Ladson, SC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Charleston Neuroscience Inst
2172
mi
from 91732
Ladson, SC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Charles Retina Institution
1601
mi
from 91732
Germantown, TN
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Charles Retina Institution
1601
mi
from 91732
Germantown, TN
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Tennessee Retina, P.C.
1762
mi
from 91732
Nashville, TN
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Tennessee Retina, P.C.
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
W Texas Retina Consultants PA
1057
mi
from 91732
Abilene, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
W Texas Retina Consultants PA
1057
mi
from 91732
Abilene, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Texas Retina Associates
1205
mi
from 91732
Arlington, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
1205
mi
from 91732
Arlington, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Austin Retina Associates
1211
mi
from 91732
Austin, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Austin Retina Associates
1211
mi
from 91732
Austin, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Research Center
1211
mi
from 91732
Austin, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Research Center
1211
mi
from 91732
Austin, TX
Click here to add this to my saved trials